EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure

Jason L Guichard, Eric L Bonno, Michael E Nassif, Taiyeb M Khumri, David Miranda, Orvar Jonsson, Hirak Shah, Tamas Alexy, Gregory P Macaluso, James Sur, Gavin Hickey, Patrick McCann und 19 weitere

JACC: Heart Failure · 2024-11 · 12 (11) · 1879-1893

DOI: 10.1016/j.jchf.2024.05.017 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift JACC: Heart Failure, 2024-11. Verfasst von Jason L Guichard und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Section for Advanced Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support, Prism…. Hauptthemen laut MEDLINE: Heart Failure, Pulmonary Artery. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Monitoring supine pulmonary artery pressures to guide heart failure (HF) management has reduced HF hospitalizations in select patients. OBJECTIVES: The purpose of this study was to evaluate the effect of managing seated mean pulmonary artery pressure (mPAP) with the Cordella Pulmonary Artery sensor on outcomes in patients with HF. METHODS: Following GUIDE-HF (Hemodynamic-GUIDEd Management of Heart Failure Trial), with U.S. Food and Drug Administration input, PROACTIVE-HF (A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients trial) was changed from a randomized to a single-arm, open label trial, conducted at 75 centers in the USA and Europe. Eligible patients had chronic HF with NYHA functional class III symptoms, irrespective of the ejection fraction, and recent HF hospitalization and/or elevated natriuretic peptides. The primary effectiveness endpoint at 6 months required the HF hospitalization or all-cause mortality rate to be lower than a performance goal of 0.43 events/patient, established from previous hemodynamic monitoring trials. Primary safety endpoints at 6 months were freedom from device- or system-related complications or pressure sensor failure. RESULTS: Between February 7, 2020, and March 31, 2023, 456 patients were successfully implanted in modified intent-to-treat cohort. The 6-month event rate was 0.15 (95% CI: 0.12-0.20) which was significantly lower than performance goal (0.15 vs 0.43; P < 0.0001). Freedom from device- or system-related complications was 99.2% and freedom from sensor failure was 99.8% through 6 months. CONCLUSIONS: Remote management of seated mPAP is safe and results in a low rate of HF hospitalizations and mortality. These results support the use of seated mPAP monitoring and extend the growing body of evidence that pulmonary artery pressure-guided management improves outcomes in heart failure. (Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients trial [PROACTIVE-HF]; NCT04089059).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailurePulmonary ArteryAgedFemaleHumansMaleMiddle AgedHospitalizationProspective StudiesPulmonary Wedge PressureStroke Volume

Stichwörter der Autor:innen

GDMTheart failurepulmonary artery pressureremote monitoring

Autor:innen und Institutionen

  • Department of Medicine, Division of Cardiology, Section for Advanced Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support, Prisma Health-Upstate, Greenville, South Carolina, USA.
  • Saint Luke's Mid-American Heart Institute, Kansas City, Missouri, USA.
  • Department of Cardiology, Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
  • Department of Cardiology, Sanford Heart Hospital, Sioux Falls, South Dakota, USA.
  • Department of Cardiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Department of Cardiology, University of Minnesota Medical Center, Minneapolis, Minnesota, USA.

Zitieren

APA

Guichard, J. L., Bonno, E. L., Nassif, M. E., Khumri, T. M., Miranda, D., Jonsson, O., Shah, H., Alexy, T., Macaluso, G. P., Sur, J., Hickey, G., McCann, P., Cowger, J. A., Badiye, A., Old, W. D., Raza, Y., Masha, L., Kunavarapu, C. R., Bennett, M., …, & Klein, L. (2024). Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure. JACC: Heart Failure, 12(11), 1879-1893. https://doi.org/10.1016/j.jchf.2024.05.017

Vancouver

Guichard JL, Bonno EL, Nassif ME, Khumri TM, Miranda D, Jonsson O, et al. Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure. JACC: Heart Failure. 2024;12(11):1879-1893. doi:10.1016/j.jchf.2024.05.017

BibTeX
@article{Guichard2024,
  author = {Guichard, Jason L and Bonno, Eric L and Nassif, Michael E and Khumri, Taiyeb M and Miranda, David and Jonsson, Orvar and Shah, Hirak and Alexy, Tamas and Macaluso, Gregory P and Sur, James and Hickey, Gavin and McCann, Patrick and Cowger, Jennifer A and Badiye, Amit and Old, Wayne D and Raza, Yasmin and Masha, Luke and Kunavarapu, Chandra R and Bennett, Mosi and Sharif, Faisal and Kiernan, Michael and Mullens, Wilfried and Chaparro, Sandra V and Mahr, Claudius and Amin, Rohit R and Stevenson, Lynne Warner and Hiivala, Nicholas J and Owens, Max M and Sauerland, Andrea and Forouzan, Omid and Klein, Liviu},
  title = {Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure},
  journal = {JACC: Heart Failure},
  year = {2024},
  volume = {12},
  number = {11},
  pages = {1879--1893},
  doi = {10.1016/j.jchf.2024.05.017}
}
Kostenlos starten →